跳至主要内容
临床试验/ISRCTN11208146
ISRCTN11208146已完成3 期

aser acupuncture for chronic migraineParticipants: Chronic migraine (CM) patients with unsatisfactory pharmacological effectsIntervention: Laser acupuncture (LA) as an add-on preventive therapyComparisons: Sham treatment as a control groupOutcomes: Changes in monthly migraine days (MMD) and acute headache medications usage days per month from baseline

Taichung Veterans General Hospital0 个研究点目标入组 60 人开始时间: 2024年1月19日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
60

研究概览

简要总结

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/39198866/ (added 02/09/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged >20 years old and had CM managed pharmacologically, including preventive and/or acute migraine medications, and in addition, those who had refused preventive agents despite the recommendation of the neurologist
  • 2. Unsatisfactory effect of current pharmacological treatments, defined by self-reporting
  • 3. A minimum of a one-year history of migraine with or without aura

排除标准

  • 1. Received another LA therapy or traditional acupuncture at baseline
  • 2. Migraine onset after the age of 50
  • 3. Cognitive or psychological impairment interfering with the participant’s ability to receive LA protocol and describe symptoms
  • 4. Patients with missing data at baseline or during the follow-up period

研究者

相似试验